Expression ofStreptococcus pneumoniaeantigens, PsaA (pneumococcal surface antigen A) and PspA (pneumococcal surface protein A) byLactobacillus casei
- 1 October 2003
- journal article
- Published by Oxford University Press (OUP) in FEMS Microbiology Letters
- Vol. 227 (1) , 25-31
Abstract
A number of recent research works in lactic acid bacteria aim towards the design of new strains that could be used as live vectors for the delivery of antigens for oral vaccination, or other therapeutic molecules. In this work, an inducible expression system based on the Lactobacillus casei lactose operon promoter was used to express three important surface antigens of Streptococcus pneumoniae in this lactic acid bacterium: a virulence-related pneumococcal surface antigen (PsaA) and two variants of the virulence factor PspA (pneumococcal surface protein A). Expression of the three proteins was induced upon growth on lactose and strongly repressed by glucose. These proteins were produced intracellularly. Also, secretion to the growth medium was achieved by means of a fusion to the secreting and processing signals from the L. casei surface proteinase. Interestingly, while secreted PspA proteins were found in the culture supernatants, PsaA remained trapped in the cell wall. Expression of pneumococcal antigens in a food-grade organism opens an alternative for mucosal vaccination against this important pathogen.Keywords
This publication has 27 references indexed in Scilit:
- PsaA (pneumococcal surface adhesin A) and PspA (pneumococcal surface protein A) DNA vaccines induce humoral and cellular immune responses against Streptococcus pneumoniaeVaccine, 2001
- Genetic Immunization with the Region Encoding the α-Helical Domain of PspA Elicits Protective Immunity againstStreptococcus pneumoniaeInfection and Immunity, 2001
- Pneumococcal Virulence Factors: Structure and FunctionMicrobiology and Molecular Biology Reviews, 2001
- Use of a Whole Genome Approach To Identify Vaccine Molecules Affording Protection against Streptococcus pneumoniae InfectionInfection and Immunity, 2001
- Use of live bacterial vaccine vectors for antigen delivery: potential and limitationsVaccine, 2001
- The potential to use PspA and other pneumococcal proteins to elicit protection against pneumococcal infectionVaccine, 2000
- Intranasal Immunization of Mice with a Mixture of the Pneumococcal Proteins PsaA and PspA Is Highly Protective against Nasopharyngeal Carriage ofStreptococcus pneumoniaeInfection and Immunity, 2000
- Study of the Possible Mechanisms Involved in the Mucosal Immune System Activation by Lactic Acid BacteriaJournal of Dairy Science, 1999
- Instruments for oral disease-intervention strategies: recombinant Lactobacillus casei expressing tetanus toxin fragment C for vaccination or myelin proteins for oral tolerance induction in multiple sclerosisVaccine, 1999
- Safety and immunogenicity of tetravalent pneumococcal vaccines containing 6B, 14, 19F and 23F polysaccharides conjugated to either tetanus toxoid or diphtheria toxoid in young infants and their boosterability by native polysaccharide antigensThe Pediatric Infectious Disease Journal, 1997